Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ J+d1&Tw&
OO[F E3F
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© b[V^86X^
Xd^\@
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© y
WV#Up
yR(x+Gs{]
1.Co-stimulators (or co-stimulating molecules) Yn8=
g=I8@m
2.NK-kB (?nCyHC%g
`ZC<W]WYX/
3.Immunoglobulin superfamily x c{hC4^V
M(/r%-D
4.antigen-presenting cell (APC) As>_J=8} 3
%2v4<icvq
5.death domain 0jEL<TgC
M![J2
=
6.CCR and CXCR &RfC"lc
e=.]F
*:J
7.Lectin (or mitogen) H)n9O/u
K.0:
C`C
8.Clusters of differentiation, CD) E~6c -
Lw
A{A\RSZ0
9.B7 family [UH||qW
0=?<y'=
10.Cytotoxic T lymphocyte, CTL) >rf'-X4n
=uS9JU^E
11.IL-15 and IL-15 receptor (IL-15R) OynXkH]0T+
pS:4CNI{
12.MHC restriction -PfX0y9n
s=;uc]9g
13.Affinity-chromatography Fx2bwut.K
3eF-8Z(f
14.Cyctosprin A, CsA P(f0R8BE
H5Io{B%=
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) =o$sxb
E(
tIuCct-
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© BW$"`T@c6~
i uF*.hc,%
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 '2 PF
{y_98N
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ]d!
UJ&<?
Q|#W#LV,K
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ &tg&5_
PoxK{Y
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© (pv+c,
*GL/aEI<$
ÃâÒßѧרҵ£º 2#c<\s|C
d?A
0MKnl
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ s~5[![1
K
z=q3Zo
Ïû»¯ÄÚ¿Æ£º wk5s)%V
)b)-ZS7
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ b4[bL2J$h1
/`wvxKX
ѪҺ²¡Ñ§×¨Òµ£º onz?_SAW
`p2+&&]S
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿